Silverfin false false 31/12/2024 01/01/2024 31/12/2024 A Wastnage 10/08/2020 R J Wastnage 10/08/2020 13 December 2025 no description of principal activity 12801386 2024-12-31 12801386 bus:Director1 2024-12-31 12801386 bus:Director2 2024-12-31 12801386 2023-12-31 12801386 core:CurrentFinancialInstruments 2024-12-31 12801386 core:CurrentFinancialInstruments 2023-12-31 12801386 core:Non-currentFinancialInstruments 2024-12-31 12801386 core:Non-currentFinancialInstruments 2023-12-31 12801386 core:ShareCapital 2024-12-31 12801386 core:ShareCapital 2023-12-31 12801386 core:SharePremium 2024-12-31 12801386 core:SharePremium 2023-12-31 12801386 core:RetainedEarningsAccumulatedLosses 2024-12-31 12801386 core:RetainedEarningsAccumulatedLosses 2023-12-31 12801386 core:Vehicles 2023-12-31 12801386 core:Vehicles 2024-12-31 12801386 core:CostValuation 2023-12-31 12801386 core:CostValuation 2024-12-31 12801386 core:AdditionsToInvestments 2024-12-31 12801386 core:DisposalsRepaymentsInvestments 2024-12-31 12801386 core:RevaluationsIncreaseDecreaseInInvestments 2024-12-31 12801386 1 2024-12-31 12801386 1 2023-12-31 12801386 2022-12-31 12801386 core:FurtherSpecificItem1DeferredTaxComponentTotalForDeferredTax 2024-12-31 12801386 core:FurtherSpecificItem1DeferredTaxComponentTotalForDeferredTax 2023-12-31 12801386 core:FurtherSpecificItem2DeferredTaxComponentTotalForDeferredTax 2024-12-31 12801386 core:FurtherSpecificItem2DeferredTaxComponentTotalForDeferredTax 2023-12-31 12801386 2024-01-01 2024-12-31 12801386 bus:FilletedAccounts 2024-01-01 2024-12-31 12801386 bus:SmallEntities 2024-01-01 2024-12-31 12801386 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 12801386 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 12801386 bus:Director1 2024-01-01 2024-12-31 12801386 bus:Director2 2024-01-01 2024-12-31 12801386 core:Vehicles 2024-01-01 2024-12-31 12801386 2023-01-01 2023-12-31 12801386 core:Associate1 2024-01-01 2024-12-31 12801386 core:Associate1 1 2024-01-01 2024-12-31 12801386 core:Associate1 1 2023-01-01 2023-12-31 12801386 core:JointVenture1 2024-01-01 2024-12-31 12801386 core:JointVenture1 1 2024-01-01 2024-12-31 12801386 core:JointVenture1 1 2023-01-01 2023-12-31 12801386 core:CurrentFinancialInstruments 2024-01-01 2024-12-31 iso4217:GBP xbrli:pure decimalUnit

Company No: 12801386 (England and Wales)

RNIE GROUP LIMITED

Unaudited Financial Statements
For the financial year ended 31 December 2024
Pages for filing with the registrar

RNIE GROUP LIMITED

Unaudited Financial Statements

For the financial year ended 31 December 2024

Contents

RNIE GROUP LIMITED

COMPANY INFORMATION

For the financial year ended 31 December 2024
RNIE GROUP LIMITED

COMPANY INFORMATION (continued)

For the financial year ended 31 December 2024
DIRECTORS A Wastnage
R J Wastnage
REGISTERED OFFICE 4th Floor Cumberland House
15-17 Cumberland Place
Southampton
SO15 2BG
United Kingdom
COMPANY NUMBER 12801386 (England and Wales)
ACCOUNTANT S&W Partners LLP
4th Floor Cumberland House
15-17 Cumberland Place
Southampton
Hampshire
SO15 2BG
RNIE GROUP LIMITED

BALANCE SHEET

As at 31 December 2024
RNIE GROUP LIMITED

BALANCE SHEET (continued)

As at 31 December 2024
Note 2024 2023
£ £
Fixed assets
Tangible assets 3 117,803 0
Investments 4 55,960,411 75,389,336
56,078,214 75,389,336
Current assets
Debtors
- due within one year 5 5,691,556 1,769,845
- due after more than one year 5 1,800,000 0
Investments 6 3,333,400 0
Cash at bank and in hand 6,263,156 673,727
17,088,112 2,443,572
Creditors: amounts falling due within one year 7 ( 169,493) ( 209,076)
Net current assets 16,918,619 2,234,496
Total assets less current liabilities 72,996,833 77,623,832
Provision for liabilities 8 ( 95,346) 0
Net assets 72,901,487 77,623,832
Capital and reserves
Called-up share capital 10,405,380 10,405,380
Share premium account 64,748,830 64,748,830
Profit and loss account ( 2,252,723 ) 2,469,622
Total shareholders' funds 72,901,487 77,623,832

For the financial year ending 31 December 2024 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The financial statements of RNIE Group Limited (registered number: 12801386) were approved and authorised for issue by the Board of Directors on 13 December 2025. They were signed on its behalf by:

R J Wastnage
Director
RNIE GROUP LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2024
RNIE GROUP LIMITED

NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 31 December 2024
1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

General information and basis of accounting

RNIE Group Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is 4th Floor Cumberland House, 15-17 Cumberland Place, Southampton, SO15 2BG, United Kingdom.

The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with ‘The Financial Reporting Standard applicable in the UK and the Republic of Ireland’ issued by the Financial Reporting Council, including Section 1A of Financial Reporting Standard 102 (FRS102), and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.

The functional currency of RNIE Group Limited is considered to be pounds sterling because that is the currency of the primary economic environment in which the Company operates.

These financial statements are separate financial statements.

Going concern

The financial statements have been prepared on a going concern basis.

The directors have made an assessment in preparing these financial statements as to whether the Company is a going concern and have concluded that there are no material uncertainties that may cast significant doubt on the Company's ability to continue as a going concern for a period of at least 12 months from the date of approval of these financial statements.

Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Balance Sheet date are reported at the rates of exchange prevailing at that date.

Exchange differences are recognised in the Statement of Comprehensive Income in the period in which they arise on monetary items.

Interest income

Interest income is recognised in profit or loss using the effective interest method.

Dividend income

Dividend income from investments is recognised when the shareholders' rights to receive payment have been established (provided that it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably).

Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.

Deferred tax
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the Company's financial statements. Deferred tax is provided in full on timing differences which result in an obligation to pay more or less tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on enacted or substantively enacted tax rates and laws. Deferred tax assets and liabilities are not discounted.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit. Deferred tax assets are recognised only to the extent that it is probable that future taxable profit will be available against which the temporary differences can be utilised.

Tangible fixed assets

Tangible fixed assets are stated at cost or valuation, net of depreciation and any provision for impairment. Depreciation is provided on all tangible fixed assets, other than investment property and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a reducing balance basis over its expected useful life, as follows:

Vehicles 20 % reducing balance

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

Trade and other creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers.

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.

Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

Non-basic financial instruments, including loan notes with contingent features, are measured at fair value through profit or loss in accordance with FRS 102 Section 12. Fair value is determined using valuation techniques based on unobservable inputs such as forecast performance and expected exit timing.

Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less accumulated impairment.

Fair value measurement
The best evidence of fair value is a quoted price for an identical asset in an active market. When quoted prices are unavailable, the price of a recent transaction for an identical asset provides evidence of fair value as long as there has not been a significant change in economic circumstances or a significant lapse of time since the transaction took place. If the market is not active and recent transactions of an identical asset on their own are not a good estimate of fair value, the fair value is estimated by using a valuation technique.

Provisions

Provisions are recognised when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle that obligation and a reliable estimate can be made of the amount of the obligation.

The amount recognised as a provision is the best estimate of the consideration required to settle the present obligation at the Balance Sheet date, taking into account the risks and uncertainties surrounding the obligation. Where a provision is measured using the cash flows estimated to settle the present obligation, its carrying amount is the present value of those cash flows (when the effect of the time value of money is material).

When some or all of the economic benefits required to settle a provision are expected to be recovered from a third party, a receivable is recognised as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders.

2. Employees

2024 2023
Number Number
Monthly average number of persons employed by the Company during the year, including directors 2 2

3. Tangible assets

Vehicles Total
£ £
Cost
At 01 January 2024 0 0
Additions 118,583 118,583
At 31 December 2024 118,583 118,583
Accumulated depreciation
At 01 January 2024 0 0
Charge for the financial year 780 780
At 31 December 2024 780 780
Net book value
At 31 December 2024 117,803 117,803
At 31 December 2023 0 0

4. Fixed asset investments

Investments in subsidiaries

2024
£
Cost
At 01 January 2024 2
At 31 December 2024 2
Carrying value at 31 December 2024 2
Carrying value at 31 December 2023 2

Listed investments Investments in associates Investments in joint ventures Loans Other investments Total
£ £ £ £ £ £
Cost or valuation before impairment
At 01 January 2024 0 73,422,844 1,966,490 0 0 75,389,334
Additions 35,943,777 0 0 15,000,000 3,057,389 54,001,166
Disposals ( 6,855,490) ( 73,422,844) 0 0 0 ( 80,278,334)
Movement in fair value 213,539 0 0 6,600,000 34,704 6,848,243
At 31 December 2024 29,301,826 0 1,966,490 21,600,000 3,092,093 55,960,409
Carrying value at 31 December 2024 29,301,826 0 1,966,490 21,600,000 3,092,093 55,960,409
Carrying value at 31 December 2023 0 73,422,844 1,966,490 0 0 75,389,334

Other investments comprise holdings in hedge funds and private equity vehicles that are not listed on a recognised stock exchange. These investments are valued at fair value based on the latest available net asset value (NAV) provided by the fund managers.

Loans comprise of a loan note with contingent performance-linked features. The loan note is a non-basic financial instrument measured at fair value through profit or loss in accordance with FRS 102 Section 12. Fair value is determined using expected probabilities of various outcomes of performance. Inputs are classified as Level 3 under the fair value hierarchy as they include unobservable assumptions. The fair value movement of £6,600,000 during the year has been recognised in Other finance income. Valuation involves significant judgment and estimation uncertainty.

Investments in shares

Investments in associates

The following were associates of the Company:

Name of entity Registered office Class of
shares
Ownership
31.12.2024
Ownership
31.12.2023
Qualasept Holdings Limited 3 Corsham Science Park, Park Lane, Corsham, Wiltshire, United Kingdom, SN13 9FU Ordinary 45.00% 45.00%

During the year, the company disposed of its shareholding in Qualasept Holdings Limited, an associate company.

Investments in joint ventures

The following were joint ventures of the Company:

Name of entity Registered office Class of
shares
Ownership
31.12.2024
Ownership
31.12.2023
Johafiky Investments Limites c/o Bpb Accountancy Ltd Paulton House, Old Mills, Paulton, Bristol, BS39 7SX Ordinary 50.00% 50.00%

5. Debtors

2024 2023
£ £
Debtors: amounts falling due within one year
Amounts owed by Group undertakings 3,318,218 1,769,845
Accrued income 1,026 0
Other debtors 2,372,312 0
5,691,556 1,769,845
Debtors: amounts falling due after more than one year
Short term loans to joint ventures 1,800,000 0

Other debtors represents the earn-out consideration to be received in 2025, from the disposal of Qualasept in August 2024.

6. Current asset investments

2024 2023
£ £
Rothschild Money Market Investments, 4.65% 3,333,400 0

7. Creditors: amounts falling due within one year

2024 2023
£ £
Amounts owed to directors 19,472 169,472
Accruals 62,639 39,604
Taxation and social security 87,382 0
169,493 209,076

The director's loan is interest free and repayable on demand.

8. Deferred tax

2024 2023
£ £
At the beginning of financial year 0 0
Charged to the Profit and Loss Account ( 95,346) 0
At the end of financial year ( 95,346) 0

The deferred taxation balance is made up as follows:

2024 2023
£ £
Fixed asset timing differences ( 29,451) 0
Capital gains ( 65,895) 0
( 95,346) 0

9. Related party transactions

The Company has taken the available exemption under FRS102 Section 1A to not disclose related party transactions with other wholly owned group companies. Details of the debtor balances held with group companies can be found in note 5. The amounts are repayable on demand and no interest is charged on the balances.

During the year the Company received dividends totalling £1,415,250 (2023: £733,500) from its associate Qualasept Holdings Limited.

During the year, the company disposed of its shareholding in Qualasept Holdings Limited, an associate company. The transaction was conducted at arm’s length and on normal commercial terms. As consideration for the disposal, the company received £42,670,476 in cash, loan notes with a fair value of £21,600,000, and deferred earn-out consideration to be received in 2025, amounting to £2,372,312.

During the year the directors maintained a loan account with the Company. During the year the directors advanced the Company £nil (2023: £nil) and were repaid £150,000 (2023: £nil). At the year-end the Company owed the directors £19,472 (2023: 169,472). This loan is interest free, repayable on demand and shown within other creditors.